Research into the gut microbiome has positioned the industry at the core of personalized nutrition and diet. With the global market of probiotics projected to be worth $64Bn by 2024 and a boom in consumer consciousness around wellness following the pandemic, a new wave of product development is occurring.Microbiome Connect: Nutrition is the second global event dedicated to transforming microbiome R&D into consumer products that promote wellbeing. Tune in to meet the nutrition ecosystem across; big nutrition, consumer Health, CPG companies, independent nutrition brands, ingredients producers and formulators. Key challenges and solutions being discussed include;Customer retention - Retain customers through gut microbiome personalized diagnosticsand regimes.Claims development - Develop a better understanding of the regulatory status of products and the claims that can be made and establish methodology for developing trials to establish new claims for their productsPartnerships - Network across the ecosystem leading to new product development partnerships, investment and supply-chain.Product development - Protecting IP and enaching product development and pipeline.Trend identification - Develop better consumer insights to determine the scientific language consumers and understand and what they will buy through spotting future trends. Utilize these learnings in the branding of marketing of your products.Join Microbiome Connect: Nutrition to meet with science and business leaders from the microbiome field to transform microbiome research and innovation into successful and effective consumer products.
Join us at the International Phage Futures Congress in 2021, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all over the world. Experts in their respective fields will discuss how to translate new phage-based applications into clinical studies & beyond.Discover how you can be at the forefront of the developing phage therapy market.Network & learn from established biotech companies, emerging start-ups, leading academics, global accelerator representatives, investment firms, international healthcare organisations & regulatory bodies. Among other topics, expect to hear & participate in:Advice on how to successfully navigate clinical trial progression to prove efficacy along with recent developments from leading biotechs in phage therapeutic trials targeting chronic & acute illnesses.Regulatory discussions between international governing bodies with region specific follow-up conversations with the experts.Insights into new fields for phage application, such as oncology, diagnostics & microbial gene therapy.Expert advice on how to find & secure financial investments.
Partnerships and Innovation: Driving the Personalized Nutrition Industry ForwardThe global Personalized Nutrition market is forecasted to grow to $16.6 billion USD by 2027. Increasing consumer awareness about the role of nutrition on wellbeing and immunity (in part driven by Covid-19), coupled with the rise in digital health tools, testing kits, and wearables, is exacerbating this trend. There is also increasing acceptance in the healthcare industry that the “one-size-fits-all” approach to nutrition has failed, and that personalized approaches have a critical part to play in preventative care.However, despite potential, there are still considerable challenges preventing this industry from becoming mainstream. Start-ups in this space are struggling with customer retention & feedback and proving that their products work, and CPG firms and supplement brands are still assessing how best to invest in “the personal”. This Summit will provide the perfect forum for the CEO’s and founders of innovative personalized nutrition start-ups to meet with potential partners and investors. It will bring together CPG firms, supplement brands, and start-ups who are specializing in this space, to foster further partnerships and innovation.
